How to Investigate Bilateral Breast Nipple Discharge: An Account of Extra-mammary Causes and their Management
DOI:
https://doi.org/10.48111/2021.02.11Keywords:
Nipple Discharge, Breast Cancer, Prolactinoma, Assessment , Surgical ManagmentAbstract
Nipple discharge is a common presentation with multiple causes including physiological, systemic and breast related causes. Investigations and management depend on the underlying cause. Detailed history & examination is often very helpful and investigations can confirm the clinical suspicion. This review is mainly focused on extra-mammary or systemic causes of breast discharge. Systemic causes are mainly investigated by medical team but many cases will need surgical input to fix the cause such as prolactinoma.
References
Louise LD, Crowe JP, Dawson AE, et al.: Identification of breast cancer in patients with pathological nipple discharge: does ductography predicts malignancy? Am J Surg (2006); 192: 530-533.
Florio MA, Fam F, Giacombbe G, et al.: Nipple discharge, experience with 2818 cases. Chirurgia Italiana (2003): 55: 357-363.
Gray RJ, Pockaj BA, Karstaedt PJ: Navigating murky waters: a modern treatment algorithm for nipple discharge. Ann J Surg (2007):194;850-855.
Morrough M, Morris EA, Liberman L, et al.: The predictive value of ductography and MRI in the management of nipple discharge. Ann Surg Oncol (2007); 14:3369-3377.
Lamont JP, Dultz RP, Kuhn JA, et al.: Ductography in patients with nipple discharge. BUMC Proc (200); 13:214-216.
Denewer A, El-Erribi K, Nada N, et al.: The role and limitation of ductoscopy in managing pathological nipple discharge.
Trott JF, Vonderhaar BK, Hovey RC: Historical perspective of prolactin and growth hormone as mammogens, lactogens, and galactagogues- Agog for the future. J Mammary Gland Biol. Neoplasia (2008);13;3-11.
Freeman ME, Kanyicska B, Lerant A et al. Prolactin: structure, function, and regulator of secretion. Physiol Rev (2000): 80; 1523-1631.
Marano RJ, Ben-Jonathan N. Minireview: Extrapiyuitary prolactin. An update on the distribution, regulation, and functions. Mol. Endocrinol (2014):28;622-633.
Levine S, Muneyyirci-DO: Stress-induced hyperprolactinemia. Pathophysiology and clinical approach. Obs. Gynaecol. Int (2018):9253083.
Melrned S, Casanueva FF, Hoffman AR, et al.: Diagnosis & treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab (2011):96;273-288.
Maiter D, Delgrange E: Therapybof endocrine disease: The challenge in managing giant prolactinomas. Eur J. Endocrinol (2014):170;213-227.
Sharma LK, Sharma N, Gadpayle AK et al.: Prevalence & predictors of hyperprolactinemia in subclinical hypothyroidism. Eur J Intern. Med. (2016): 35; 106-110.
Honbo KS, van Herle AJ, Kellett KA: serum prolactin levels in untreated primary hypothyroidism. Am J. Med (1978):64; 782-787.
Peuskens J, Pani L, Detraux J, et al.: The effects of newly approved antipsychotics on serum prolactin levels. A comprehensive review: CNS Drugs (2014):28;421-453.
Vilar L, Fleseriu M, Bronstein MD: Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq. Bras. Endocrinol. Metab (2014):58;9-22.
Montejo A, Arango C, Bernardo M, et al.: Spanish consensus on the risk & detection of antipsychotic related hyperprolactinemia. Rev. Psiquiatr. Salud Ment (2016):9;158-173.
Casanuvea FF, Molitch ME, Schlechte JA et al.: guidelines of the pituitary society for diagnosis and management of prolactinomas. Clin Endocrinol. Oxf (2006):65;265-273.
Molitch ME, Management of medically refractory prolactinoma: J. neurooncol (2014):117;421-428.
Souteiro P, Karavitaki N. Dopamine agonist resistant prolactinoma: any alternative medical treatment? Pituitary (2019):1-11.
Nakhleh A, Shehadeh N, Hochberg I et al.: Management of cystic prolactinoma: a review. Pituitary (2018):21;425-430.
Tampourlou M, Trifanescu R, Paluzzi A, et al.: Therapy of endocrine diseases: Surgery in micro prolactinomas: Effectiveness and risks based on contemporary literature. Eur. J. Endocrinol. (2016):175; R89-R96.
Ntali G, Karavitaki N: Efficacy and complications of pituitary irradiations. Endocrinol. Metab. Clin. N. Am. (2015):44;117-126.
Grigg J, Worsley R, Thew C et al. Antipsychotic induced hypercalcemia: synthesis of worldwide guidelines and integrated recommendations for assessment, management, and future research. Psychopharmacology (2017):234;3279-3297.
Stefanos Z, Georgos I, Panagiotis E et al.: Nipple discharge screening: Women's health (2010): 6(1);135-151
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Asif Hussain
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
